AU Patent

AU2016328365B2 — New bicyclic compounds as dual ATX/CA inhibitors

Assigned to F Hoffmann La Roche AG · Expires 2020-04-23 · 6y expired

What this patent protects

The invention provides novel compounds having the general formula (I) wherein R

USPTO Abstract

The invention provides novel compounds having the general formula (I) wherein R

Drugs covered by this patent

Patent Metadata

Patent number
AU2016328365B2
Jurisdiction
AU
Classification
—
Expires
2020-04-23
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.